General Moderna, Merck Say mRNA Vaccine Prevents Melanoma From ReturningBy Healthcare Propulsion StaffAugust 19, 20260 An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, in a large, closely watched trial, the…
General Moderna stock more than doubles after melanoma vaccine trial shows “landmark moment”By Healthcare Propulsion StaffAugust 19, 20260 Drugmaker Moderna’s stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat…
